Sarcomatrix Therapeutics Extends Accredited Investor Round to October 31

Untitled_design_-_2026-10-01T174916663_1790859637ifEvwe1vnh

Sarcomatrix Therapeutics Corp.

Format

JPEG

Source

Sarcomatrix Therapeutics Corp.

Téléchargements